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1. Introduction
Liver fibrosis develops as a sequel of chronic liver injury of various etiologies, including vi‐
ral infection, immunological reaction, and toxic and metabolic insults, and is characterized
by the accumulation of extracellular matrix(ECM) components produced by fibroblast-like
cells including activated stellate cells and myofibroblasts in the hepatic parenchyma. Hepat‐
ic fibrosis progresses towards cirrhosis, an end-stage liver injury, leading to hepatic failure,
hepatocellular carcinoma, and finally death. Hepatitis C virus (HCV) infection is the most
common cause of liver fibrosis. HCV infects approximately 170 million individuals world‐
wide according to a report from the
World Health Organization [1]. Liver biopsy has been considered the ‘gold standard’ meth‐
od for the evaluation of liver fibrosis in chronic hepatitis C [2]. However, liverbiopsy has
some limitations, including its invasiveness, risk of complications, sampling error, variabili‐
ty in histopathological interpretation, and the reluctance of patients to subject to repeated
examinations [3-11].Because of these disadvantages, there is a growing shift inclinical prac‐
tice to utilize or develop ‘non-invasive’methodologies to evaluate the stage of liver fibrosis.
In particular, liver stiffness measurement by Vibration-Controlled Transient Elastography
(Fibroscan) has become establishedas an important modality. Recently we and other investi‐
gator reported the usefulness of real-time tissue elastography (RTE) for noninvasive, visual
assessment of liver stiffness in patients with chronic hepatitis C [12.13]. RTE is a method in‐
tegrated in a sonography machine and developed in Japan for the visual assessment of tis‐
sue elasticity, based on a Combined Autocorrelation Method that calculates rapidly the
relative hardness of tissue from the degree of tissue distortion and which displays this infor‐
mation as a color image [14]. This technology has already been proved to be diagnostically
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valuable in the breast cancer [15]. We show here the additional value of RTE, in comparsion
to Fibroscanin patients with chronic liver disease.
2. Principle of elastography imaging
The two major categories of non-invasive hepatic elasticity imaging are dynamic elastogra‐
phy techniques, such as Fibroscan, and static elastography techniques, such as RTE. At
present the dynamic elastography techniques have the advantage of allowing a quantitative
imaging and better resolution than the static elastography techniques. These techniques re‐
quire more complex equipment for the generation mode and imaging modalities. Ultra‐
sound and magnetic resonance imaging are the major imaging modalities. The dynamic
elastography techniques may be devided into two groups, based on the method of generat‐
ing the shear wave: remote generation using radiation force and mechanical vibration. Of
the static elastography techniques, real time tissue elastography developed by Hitachi Medi‐
cal is most advanced ultrasound technique and can reveal tissue distortion using the hart
beat and pulsing of the aorta. Several elastography techniques are summarized in Table 1.
Principle Mode of generation Imaging modality
Real-time Tissue Elastography (RTE) Tissue distortion Pulsing of the aorta Ultrasound
Vibration-Controlled Transient
Elastography (VCTE, Fibroscan)
Propagating shear wave Mechanical vibration Ultrasound
Acoustic Radiation Force Impulse
(ARFI)
Propagating shear wave Radiation force Ultrasound
Magnetic Resonance Elastography
(MRE)
Propagating shear wave Mechanical vibration Magnetic resonance
imaging
Supersonic Shear Imaging (SSI) Propagating shear wave Radiation force Ultrasound
Table 1. Elastography techniques for measurement of liver stiffness.
3. Real time tissue elastography
The principle underlining RTE is shown in Figure 1A, which illustrates this as a spring mod‐
el [16]. When a spring is compressed, the displacement in each section of the spring depends
on its stiffness: a soft spring compresses more than a hard spring. The strain distribution can
be measured by differentiating the spatial displacement at each location. Although the tissue
displacement usually is generated by manual compression and relaxation of the probe in
practice, we were able to improve the acquisition of RTE images representing the distortion
of liver tissue as a result of the beating of the heart or pulsing of the abdominal aorta.
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RTE is carried out using a high quality ultrasound system (Hitachi AlokaMedical, Chiba, Ja‐
pan). The software uses a complex algorithm to process in a very short time all the data
coming from the lesion as radiofrequency impulses and to minimize the artifacts due to lat‐
eral dislocations, allowing accurate measurement of the degree of tissue distortion. We used
the Hitachi EUB-8500 and EUP-L52 Linear probe (3–7 MHz; Hitachi AlokaMedical) for RTE.
Figure 1. The principle and procedure of image analyses for real-time tissue elastography.(A) When a spring is com‐
pressed, displacement in each section of the spring depends on the stiffness of that part of the spring: a soft section
compresses more than a hard section. The strain distribution can be measured by differentiating the spatial displace‐
ment at each location. (B) The ROI was fixed to a rectangle of approximately 20-30 mm length x 20 mm breadth with
a 400–600 mm2 area located 5-10 mm below the surface of the liver.left; RTE image, right; B-mode image. (C-D) The
color-coded images from the ROI of the RTE were analyzed by the software Elasto_ver1.5.1. The colors ranged from
blue to red indicating the relative gradients from hardness to softness. The Mean and Standard deviation were calcu‐
lated by a histogram, which was generated by 256 stepwise grading derived from the color image. The Area and Com‐
plexity were calculated from the binary image. Area was derived from the percentage of white regions (asterisks, i.e.
hard area). Complexity was calculated asperiphery2/Area. Median value of the data were recorded as representative
of RTE parameters.
This system is currently commercially available for the diagnosis of mammary neoplasm.
Patients were examined in a supine position with the right arm elevated above the head,
and were instructed to hold their breath. The examination was performed on the right lobe
of the liver through the intercostal space, and liver biopsy and Fibroscan also were per‐
formed at the same site. The RTE equipment displays two images simultaneously; one
shows the regions of interest (ROI) as a colored area and the other indicates the conventional
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B-mode image (Fig. 1B). We chose an area where the tissue was free from large vessels and
near the biopsy point. The measurement was fixed to a rectangle 30 mm in length and 20
mm in breadth located 5-10 mm below the surface of the liver (Fig. 1B). The color in the ROI
was graded from blue (representing hard areas) to red (representing soft areas, Fig. 1B). We
stored the RTE images for 2- 3min as moving digital images (Fig. 1B) and ten static images
were captured at random from the moving images by the observer using AVI2JPG v6.10
converter software (Novo, Tokyo, Japan) and analyzed on a personal computer using the
novel software Elasto_ver 1.5.1,which was developed and donated by Hitachi Medical. Nu‐
merical values of pixels were from 0 to 255 (256 stepwise grading) according to color map‐
ping from blue (0) to red (255), and a histogram of the distribution was generated (Fig. 1C).
The scale ranged from red for components with the greatest strain (i.e., the softest compo‐
nents) to blue for those with no strain (i.e., the hardest components). Green indicated aver‐
age strain in the ROI, and therefore intact liver tissue was displayed as a diffuse
homogeneous green pattern. An appearance of unevenness in the color pattern was consid‐
ered to reflect a change in the liver stiffness. For quantification, all pixel data in the colored
image were transferred into a histogram and binary image (Fig. 1C, D).
4. Vibration-controlled transient elastography (Fibroscan)
Fibroscan, which has been developed for the measurement of liver stiffness, is currently con‐
sidered to reflect the degree of liver fibrosis directly and better than other methods. Fibro‐
Scan502 was developed by ECOSENS (Paris, France) to evaluate liver fibrosis noninvasively
in a short examination period by measuring the propagation of low frequency signals of a
mechanical shear wave running through the liver tissue. Fibroscan measures liver stiffness
in a volume that approximates a cylinder 10-mm wide and 40-mm in length between 25 and
65 mm below the skin surface. This volume is at least 100 times greater than that obtained
by liver biopsy and is therefore considered to be far more representative of the condition of
the hepatic parenchyma [17-21].The results that were obtained from ten valid measurements
with a success rate of at least 60% and an interquartile range under 30% were considered
successful. Failure was defined as when fewer than ten valid measurements were obtained.
The median of 10 valid measurements was expressed in kilopascals (kPa) and regarded as
the liver stiffness of a given subject.
Reports in 2005 from Castera et al. and Ziol et al. were pioneering; the liver stiffness measure‐
ments could be useful for assessing the presence of significant fibrosis (F2-4) and for suggest‐
ing the presence of cirrhosis in cohorts of patients with chronichepatitis C. The AUROCs
ranged from 0.79 to 0.83 for the prediction of F2-4 and were over 0.95 for the identification of
cirrhosis [22, 23]. Moreover, reproducibility of Fibroscan has been shown to be excellent for
both interobserver and intraobserver agreement with an intraclass correlation coefficient of
0.98 [24, 25]. Friedrich-Rust et al. [26] assessed the overall performance of TE for the diagnosis
of liver fibrosis by a meta-analysis that included fifty articles; the mean AUROCs for the diag‐
nosis of significant fibrosis, severe fibrosis, and cirrhosis were 0.84, 0.89, and 0.94, respective‐
ly. A recent report from Degos et al. [27] of amulticenter prospective study reported that the
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AUROCs for the diagnosis of significant fibrosis and cirrhosis were 0.76 and 0.90, respectively.
Table 2 shows concisely the diagnostic accuracy of Fibroscan. The limitations of this method al‐
so have been discussed; intraobserver agreement is influenced by variables, such as body mass
index (particularly when<28 kg/m2), hepatic steatosis, and flares of transaminases [17.23].
Study Patients (n) Prognosis Cutoff
(kPa)
Sen Spe PPV NPV AUC
Catera et al.
2005
n=183, CHC ≥F2
Cirrhosis
7.1
12.5
67%
87%
89%
91%
95%
77%
48%
95%
0.83
0.95
Zioi et al.
2005
n=251, CHC ≥F2
Cirrhosis
8.6
14.6
56%
86%
91%
96%
88%
78%
56%
97%
0.79
0.97
Friedrich-Rust et al.
2008
50 studies, liver
disease
≥F2
Cirrhosis
0.84
0.94
Degos et al. 2010 n=1307, viral
hepatitis
≥F2
Cirrhosis
5.2
12.9
90%
70%
34%
90%
64%
53%
72%
95%
0.76
0.79
Sen, Sensitivity; Spe, Specificity; PPV, Positive Predictive Value; NPV, Negative Predictive Value; AUC, Area Under the
Receiver-Operator-Characteristic curve; CHC, chronic hepatitis C.
Table 2. Diagnostic accuracies of transient elastography
5. Acoustic Radiation Force Impulse (ARFI) and Magnetic Resonance
Elastography (MRE)
The technology applied most recent is acoustic radiation force impulse (ARFI) imaging. AR‐
FI imaging permits evaluation of the elastic properties of a region of interest during real-
time B-mode conventional hepatic US examination. Results are expressed in meters per
second and the region of interest can be chosen using ultrasound guidance, there by avoid‐
ing large blood vessels and the ribs. Previous reports have indicated that the diagnostic
power of ARFI imaging for the staging of liver fibrosis is the same as that of Fibroscan [28.
29].
New technological advances have been made in the clinical application of MRI such as dif‐
fusion-weighted MRI and MRI elastography. The former measures the apparent diffusion
coefficient of water and the parameter is dependent on the tissue structure [30]. The latter
measures the propagation characteristic of the shear waves from an acoustic driver within
the liver. Although MRI elastography has been shown to be superior to APRI and Fibroscan
for determining the stage of fibrosis in patients with various under lying liver diseases [31],
it cannot be performed on aniron-overloaded liver because of noise. In addition, MRI takes
longer and costs more than the ultrasound-base delastographic examinations.
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6. Our results
Patients: Two hundred and one patients with chronic hepatitis received liver biopsy and Fi‐
broscan examination within one week after RTE procedure in the Department of Hepatolo‐
gy, Osaka City University Hospital between 2007 and 2010. Etiologies of chronic liver
diseases were hepatitis C virus (CHC; n=129, 64.2 %), hepatitis B virus infection (n=13, 6.5
%), non-alcohol steatohepatitis (n=30, 14.9 %), and others (n=29, 14.4 %). Liver fibrosis was
evaluated according to the METAVIR score. Table 3 shows the characteristics of the patients
who received these examinations.
Sex: male/ female 89/112
Age 55±13 y (21-80)*
BMI (kg/m2) 22.7±3.5 (14.1-33.2)*
Fibrosis stage(METAVIR Score)
F0 16
F1 98
F2 33
F3 27
F4 27
Etiology
HCV 129
NASH 30
HBV 13
Autoimmune hepatitis 9
Primary biliary cirrhosis 6
Others 14
BMI, body mass index.
Table 3. Characteristics of the patients
Results: Histological and laparoscopical examination: 16 (8 %) patients were classified as F0, 98
(49 %) as F1, 33 (16 %) as F2, 27 (13 %) as F3, and 27 (13 %) as F4 (cirrhosis). RTE was performed
successfully on all patients but Fibroscan measurements could not be obtained for 14 patients
(7.0 %)because of obesity and liver atrophy. The Mean decreased in proportion to the increase
of fibrosis score (Jonckheere–Terpstra test, p<0.0001). SD, Area, Complexity, and Fibroscan in‐
creased in proportion to the increase of fibrosis score (Jonckheere–Terpstra test, p< 0.0001).
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Figure 2. Receiver operating characteristic curves of each parameter obtained by RTE and Fibroscan for F0-1.
Table 4 shows linear regression analysis of the values obtained by RTE compared to the liver
stiffness values obtained by Fibroscan. Although simple regression analyses indicated that
Mean, SD, Area, and Complexity were all significantly correlated with liver stiffness meas‐
ured by Fibroscan, the r value did not indicate a high correlation.
Mean r=0.458
SD r=0.377
Area r=0.487
Complexity r=0.451
p<0.001)
Table 4. Correlation between fibroscan and the image features of RTE
The area under the receiver operating characteristic curve (AUC) for stage F0-1 were 0.69,
0.65, 0.69, 0.67, and 0.87 for Mean, SD, Area, Complexity, and Fibroscan, respectively (Fig
2).The AUC for stage F0-2 were 0.79, 0.70, 0.77, 0.73, and 0.87 for Mean, SD, Area, Complexi‐
ty, and Fibroscan, respectively (Fig 3). The AUC for cirrhosis (F4) were 0.78, 0.68, 0.77, 0.76,
and 0.84 for each of respective values (Fig 4).
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Figure 3. Receiver operating characteristic curves of each parameter obtained by RTE and Fibroscan for F0-2.
Figure 4. Receiver operating characteristic curves of each parameter obtained by RTE and Fibroscan for F4.
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7. Further research
Although our results showed that RTE was inferior to Fibroscan in determining the early
stage of liver fibrosis(Fig 2 and 3), Figure 4 indicated that the performance of RTE compares
favorably with that of Fibroscan for detecting liver cirrhosis in patients with chronic hepati‐
tis. Unfortunately the best method for the analysis and quantification of RTE remains un‐
clear, but this may be determined by future multicenter studies using larger patient cohorts
and the combination of these parameters will enable improvement of the accuracy of assess‐
ing hepatic fibrosis.
Fibroscan has been reported to have several limitations and disadvantages in evaluating pa‐
tients with obesity and ascites. In fact, in our study, we evaluated successfully all patients
with RTE, while Fibroscan measurements could not be obtained for fourteen patients be‐
cause of obesity and liver atrophy (data not shown).
In the future, a combination of imaging modalities and serological parameters or of different
imaging modalities will improve further the accuracy in differentiating fibrosis stages. Inter‐
estingly, Castera et al. reported that the best results were achieved by a combination of Fi‐
broscan and the Fibro Test [22]. Although ARFI, the most recent technology, Fibroscan, and
MRE are all based on shear wave propagation, RTE is constructed by an original theory
which is based on tissue distortion. The best diagnostic accuracy will be obtained by com‐
bining the RTE elasticity score with shear wave propagation.
8. Conclusion
We have described a static elastography technique, RTE, for the “noninvasive” visual assess‐
ment of liver stiffness. Although RTE was inferior to Fibroscan in determining the early
stage of liver fibrosis, the performance of RTE compares favorably with that of Fibroscan
when detecting liver cirrhosis in patients with chronic liver disease. We suggest that RTE
could also be used as a routine imaging method to evaluate the degree of liver fibrosis in
patients with other liver diseases. Future studies of larger patient cohorts will be necessary
for the validation of RTE analysis, and the combination of RTE with other clinical values in‐
cluding dynamic elastography techniques (i.e. Fibroscan, ARFI and MRE) and serum bio‐
markers will enable improvement of the accuracy of assessing hepatic fibrosis.
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